Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Additional Articles by the Author
Chase Doyle
Value-Based Care
PARP Inhibitors Least Cost-Effective as Maintenance Therapy in Advanced Ovarian Cancer
Read More
Emerging Therapies
LOXO-292 Highly Effective in RET-Positive Cancers
Read More
Breast Cancer
First-in-Class Antibody-Drug Conjugate Effective in HER2-Negative Metastatic Breast Cancer
Read More
Breast Cancer
CAR T-Cell Therapy Yields Impressive Responses in Aggressive Non-Hodgkin Lymphoma
Read More
Value-Based Care
Overcoming Barriers to Cost Transparency in Cancer Care
Read More
Value-Based Care
Novel Cancer Drugs Must Adopt Value-Based Pricing
Read More
Value-Based Care
Patients with Curable Cancer Experience Significant Symptom Burden and Hospitalization
Read More
Multiple Myeloma
Daratumumab Added to Carfilzomib, Lenalidomide, and Dexamethasone: Safe and Tolerable in Patients with Newly Diagnosed Multiple Myeloma
Read More
Immunotherapy
Adoptive T-Cell Therapy: Ready for Prime Time
Read More
Value-Based Care
Oncologists Must Begin to Discuss Financial Toxicity with Patients
Read More
1
2
3
4
5
6
7
Page 4 of 7
Results 31 - 40 of 70